Save time and get answers to complex questions with AI chat
Mobic injection patent oehringer ingelheim france?Tracleer online pharmacy?Does lipitor's use influence blood pressure medication type?When is xarelto's patent set to expire roughly?Diltiazem drug class?
See the DrugPatentWatch profile for dupixent
Dupixent’s sales grew from $1.79 billion in 2019 to $4.78 billion in 2020, which is an increase of $2.99 billion. That corresponds to a growth rate of about 167% year over year. [1][2]
The 2019 and 2020 revenue figures used above are reported as Dupixent net product sales in company financial disclosures: $1.79 billion for 2019 and $4.78 billion for 2020. [1][2]
Growth rate = (2020 − 2019) / 2019 = ($4.78B − $1.79B) / $1.79B = $2.99B / $1.79B ≈ 1.67 = 167% [1][2]
The calculation above uses net product sales for Dupixent for 2019 and 2020 as reported in the cited financial disclosures. [1][2] Sources: [1] https://www.sec.gov/ixviewer/documents/20200227x10k.htm [2] https://www.sec.gov/ixviewer/documents/20210301x10k.htm
Other Questions About Dupixent :